Ray Dalio Cerus Corp Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.79 - $2.9 $30,558 - $49,508	-17,072 Reduced 8.16%	192,212 $472,000
Q1 2023 May 12, 2023	BUY	$2.65 - $3.81 $16,077 - $23,115	6,067 Added 2.99%	209,284 $621,000
Q4 2022 Feb 13, 2023	SELL	$3.38 - $4.22 $233,808 - $291,914	-69,174 Reduced 25.4%	203,217 $741,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.83 $34 - $58	10 Added 0.0%	272,391 $981,000
Q2 2022 Aug 11, 2022	BUY	$4.41 - $5.69 $127,431 - $164,418	28,896 Added 11.87%	272,381 $1.44 Million
Q1 2022 May 13, 2022	BUY	$4.81 - $6.99 $272,347 - $395,780	56,621 Added 30.3%	243,485 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $69,156 - $91,861	11,584 Added 6.61%	186,864 $1.27 Million
Q3 2021 Nov 12, 2021	SELL	$4.79 - $6.68 $21,641 - $30,180	-4,518 Reduced 2.51%	175,280 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$5.35 - $6.35 $961,919 - $1.14 Million	179,798 New	179,798 $1.06 Million

159

146M

48.6K

8.7K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $262M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.